ArticleTrials2020

Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study.

Taek-Geun Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.